STOCK TITAN
  1. Home
  2. News
  3. LFVN

Lifevantage Corporation - LFVN STOCK NEWS

Welcome to our dedicated page for Lifevantage Corporation news (Ticker: LFVN), a resource for investors and traders seeking the latest updates and insights on Lifevantage Corporation stock.

Lifevantage Corporation Common Stock (Delaware) (symbol: LFVN) is a pioneering company in the field of nutrigenomics, a cutting-edge area of nutritional science focused on how nutrients affect gene expression to improve health and wellness. Founded on the premise that aging is inevitable but can be managed, Lifevantage offers a range of products designed to combat the effects of aging and promote overall well-being.

The company's core business involves the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. Among its flagship offerings is Protandim, a scientifically-validated dietary supplement known for its ability to reduce oxidative stress. Other notable products include the LifeVantage TrueScience anti-aging skincare line, Axio energy drink mixes, PhysIQ weight management systems, and Canine Health, a pet supplement formulated to improve the health of dogs.

Lifevantage's products are available in multiple regions, including the United States, Japan, Hong Kong, Australia, Canada, the Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands. This geographical diversification helps the company reach a broad audience and sustain its growth trajectory.

Recently, Lifevantage has made significant strides in its business operations. Hundreds of independent consultants hosted virtual watch parties to kickstart the company's initiatives for 2024. The company also continues to innovate, as seen in the second quarter of fiscal 2024 results and the upcoming launch of its Evolve Compensation Plan and Rewards Circle customer loyalty program on February 1, 2024. These initiatives are designed to enhance customer satisfaction and drive business growth.

Financially, Lifevantage is committed to transparency and accountability, regularly updating investors on its performance through detailed reports and investor relations contacts. Despite the challenges posed by COVID-19, the company has maintained a resilient stance, focusing on future growth and product expansion.

Overall, Lifevantage remains a significant player in the health and wellness industry, continually advancing the science of nutrigenomics to offer effective solutions for aging and other health-related concerns.

News

Stockholders Re-Elect All Seven LifeVantage Incumbent Directors at Fiscal Year 2024 Annual Meeting

Rhea-AI Summary
LifeVantage Corporation (Nasdaq: LFVN) announced the final, certified results of its fiscal year 2024 annual meeting of stockholders, confirming the re-election of all seven incumbent directors. The company expressed gratitude for the high turnout and stockholder support, highlighting the approval of all proposals, including the stockholders rights plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.02%
Tags
earnings
-
News

LifeVantage Declares Quarterly Dividend

Rhea-AI Summary
LifeVantage Corporation (LFVN) announces approval of $0.035 quarterly cash dividend, payable on December 15, 2023, to stockholders of record on December 1, 2023, emphasizing commitment to shareholder value and financial stability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.73%
Tags
dividends
-
News

LifeVantage Announces Financial Results for the First Quarter of Fiscal 2024

Rhea-AI Summary
LifeVantage Corporation (Nasdaq: LFVN) reported Q1 fiscal 2024 revenue of $51.4 million, down 0.8% YoY. Americas revenue increased 5.9%, U.S. revenue up 6.5%, but Asia/Pacific & Europe revenue decreased 16.6%. Total active accounts declined 10.5% YoY to 137,000. Adjusted EBITDA increased 41.4% to $4.0 million. The company announced a cash dividend of $0.035 per common share and expects FY 2024 revenue of $216-226 million and adjusted EBITDA of $16-18 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.73%
Tags
earnings
News

LifeVantage® Introduces TrueScience® TrueRenew Daily Firming Complex, A Better-than-Cosmetic Retinol Alternative

Rhea-AI Summary
LifeVantage Corporation has announced the launch of TrueScience TrueRenew Daily Firming Complex, an innovative retinol-alternative skincare product. TrueRenew is designed to complement the brand's existing products and tackle 11 visible signs of aging. The global retinol market is expected to reach $1.79 billion by 2030, and TrueRenew aims to capitalize on the rising consumer demand for retinol alternatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.04%
Tags
none
-
News

LifeVantage President and CEO Steve Fife Sends Letter to Stockholders

Rhea-AI Summary
LifeVantage Corporation reminds stockholders to vote the WHITE Proxy Card to ensure continued progress. The company highlights the importance of retaining critical directors Garry Mauro, Michael A. Beindorff, and Darwin K. Lewis. LifeVantage has avoided the decline faced by its competitors and has thrived under the leadership of its Board of Directors. Since announcing its new LV360 strategy in January 2023, LifeVantage has generated a total return of 133%, which is among the best returns for any U.S. public company in any industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
none
-
News

LifeVantage to Announce First Quarter Fiscal Year 2024 Results on November 9, 2023

Rhea-AI Summary
LifeVantage Corporation (Nasdaq:LFVN) will release financial results for Q1 2023 on November 9, 2023, after market close. A conference call for investors will be held at 2:30 p.m. MT (4:30 p.m. ET) on the same day. Webcast available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
earnings
News

ISS Recommends LifeVantage Corporation’s Stockholders Vote FOR Boardroom Change on the Radoff-Sudbury Group’s BLUE Proxy Card at the Upcoming Annual Meeting

Rhea-AI Summary
Leading proxy advisory firm ISS recommends stockholders support boardroom change at LifeVantage Corporation. They suggest electing Dayton Judd as an independent director and withholding support for long-tenured Chairman Garry Mauro. ISS highlights the poor performance and frequent management turnover under Mauro's leadership. They also note the need for refreshed board leadership and further change to benefit LifeVantage's stockholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.74%
Tags
none
-
News

LifeVantage Responds to Radoff-Sudbury Group’s False Allegations

Rhea-AI Summary
LifeVantage denies compensating consultants for providing statements to the media regarding the company's strategy, board of directors, and leadership team. The company states that the consultants who signed the statement in support of the company did so voluntarily and without any compensation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
News

The Radoff-Sudbury Group Exposes LifeVantage Corporation’s Latest Attempts to Mislead Stockholders Ahead of Annual Meeting

Rhea-AI Summary
The Radoff-Sudbury Group, which owns approximately 12.8% of LifeVantage Corporation's stock, has accused the company's Board of Directors of using pay-for-play tactics to deceive stockholders. They claim that a recent letter from a paid consultant of LifeVantage was a fake endorsement. The group also alleges that the consultant, Tyler Daniels, is a personal friend of Chairman Garry Mauro and is being paid by LifeVantage to promote the new 'Evolve' compensation plan. The Radoff-Sudbury Group is urging stockholders to vote for their nominated candidates at the upcoming Annual Meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
News

The Radoff-Sudbury Group Sets the Record Straight and Highlights Key Facts that Reinforce the Need for Targeted Boardroom Change at LifeVantage Corporation

Rhea-AI Summary
Bradley L. Radoff and Sudbury Capital Fund respond to misrepresentations and distortions in LifeVantage's recent presentation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.2%
Tags
none

FAQ

What is the current stock price of Lifevantage Corporation (LFVN)?

The current stock price of Lifevantage Corporation (LFVN) is $17.36 as of December 20, 2024.

What is the market cap of Lifevantage Corporation (LFVN)?

The market cap of Lifevantage Corporation (LFVN) is approximately 222.3M.

What does Lifevantage Corporation do?

Lifevantage Corporation specializes in nutrigenomics, researching and developing dietary supplements and skincare products to improve health and combat aging.

What are some of the key products offered by Lifevantage?

Lifevantage offers products such as Protandim, LifeVantage TrueScience skincare, Axio energy drinks, PhysIQ weight management systems, and Canine Health supplements.

In which regions are Lifevantage's products sold?

Lifevantage products are sold in the United States, Japan, Hong Kong, Australia, Canada, the Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

What recent achievements has Lifevantage made?

Lifevantage recently hosted successful virtual watch parties for 2024 and is launching the Evolve Compensation Plan and Rewards Circle loyalty program in February 2024.

How does Lifevantage contribute to the field of nutrigenomics?

Lifevantage is at the forefront of nutrigenomics, using scientific research to develop products that improve health by affecting gene expression.

What is Protandim?

Protandim is a scientifically-validated dietary supplement from Lifevantage, known for its ability to reduce oxidative stress.

How does Lifevantage support its investors?

Lifevantage maintains transparency with regular financial updates and investor relations contacts to keep investors informed about the company's performance.

What challenges has Lifevantage faced recently?

Lifevantage, like many other companies, has faced challenges from the COVID-19 pandemic but continues to focus on growth and product expansion.

Who should use Lifevantage products?

Lifevantage products are designed for individuals seeking to improve their health, manage aging, and enhance overall wellness, including pet owners with its Canine Health supplement.

What is the Evolve Compensation Plan?

The Evolve Compensation Plan is an initiative by Lifevantage set to launch in February 2024, aimed at enhancing customer satisfaction and loyalty.

Stock LFVN logo
Lifevantage Corporation

Nasdaq:LFVN

LFVN Rankings

#3766 Ranked by Market Cap
#1855 Ranked by Dividends

LFVN Stock Data

222.26M
10.24M
16.9%
37.13%
1.77%
Packaged Foods
Pharmaceutical Preparations
Link
United States of America
LEHI